A compound traditional Chinese medicine composition for treating chronic atrophic gastritis and a preparation method thereof
This compound Chinese medicine composition, consisting of cinnamon twig, codonopsis, and other herbs, employs the "promoting yang and dispelling turbidity" treatment method. It solves the problem of spleen deficiency and yang stagnation in the treatment of chronic atrophic gastritis by traditional Chinese medicine, achieving the effects of reversing gastric mucosal atrophy and intestinal metaplasia, and blocking the transformation of gastric cancer. It is suitable for primary healthcare institutions.
Patent Information
- Application Number
- CN202611155593.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-07-31
- Publication Date
- 2026-09-04
AI Technical Summary
Current TCM treatments for chronic atrophic gastritis (CAG) lack effective methods targeting the pathogenesis of "spleen deficiency and yang stagnation," making it difficult to reverse intestinal metaplasia and block the transformation process of gastric cancer. Furthermore, traditional prescriptions are prone to damaging the spleen and stomach yang or causing imbalances in cold and heat.
A compound traditional Chinese medicine composition is provided, comprising cinnamon twig, codonopsis, poria, immature bitter orange, ginger-processed pinellia, evodia, ophiopogon, dandelion, and prepared licorice. It adopts the treatment method of "promoting yang and resolving turbidity". Cinnamon twig warms and unblocks the meridians, poria promotes diuresis and eliminates dampness, immature bitter orange breaks up qi and eliminates stagnation, evodia opens up and descends with its pungent and bitter properties, and ophiopogon nourishes yin and protects the stomach, thereby restraining the warming and dryness, so as to achieve both symptomatic and root-cause treatment.
It significantly improves the clinical symptoms of patients with spleen deficiency and yang stagnation type CAG, reverses gastric mucosal atrophy and intestinal metaplasia, blocks "inflammation-cancer transformation", has high safety and few side effects, and is suitable for promotion in primary medical institutions.